July 2 (Reuters) - The U.S. Food and Drug Administration said on Friday it had authorized the use of an additional batch of Johnson & Johnson's COVID-19 vaccine manufactured at the problem-plagued Baltimore factory of Emergent BioSolutions Inc.
(Reporting by Dania Nadeem in Bengaluru; Editing by Devika Syamnath)
